公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2020 | Safety in moderate-to-severe plaque psoriasis patients with latent tuberculosis treated with guselkumab and anti-tuberculosis treatments concomitantly: results from pooled phase 3 VOYAGE 1 & VOYAGE 2 trials | Puig L.; TSEN-FANG TSAI ; Bhutani T.; Uy J.; Ramachandran P.; Song M.; You Y.; Gooderham M.; Lebwohl M. | Journal of the European Academy of Dermatology and Venereology | 23 | 17 | |
2014 | Secukinumab in plaque psoriasis - Results of two phase 3 trials | Langley R.G.; Elewski B.E.; Lebwohl M.; Reich K.; Griffiths C.E.M.; Papp K.; Puig L.; Nakagawa H.; Spelman L.; Sigurgeirsson B.; Rivas E.; TSEN-FANG TSAI ; Wasel N.; Tyring S.; Salko T.; Hampele I.; Notter M.; Karpov A.; Helou S.; Papavassilis C. | New England Journal of Medicine | 1599 | 1450 |